Hohneker John 4
4 · ArriVent BioPharma, Inc. · Filed May 20, 2024
Insider Transaction Report
Form 4
Hohneker John
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-16+29,550→ 29,550 totalExercise: $20.15Exp: 2034-05-15→ Common Stock (29,550 underlying)
Footnotes (1)
- [F1]These options vest annually in equal installments over three years, subject to the Reporting Person's continued service through the applicable vesting date.